Skip to main content
SpringerLink
Log in

Targeting the GABAB Receptor for the Treatment of Substance Use Disorder

  • Chapter
  • First Online:
GABAB Receptor

Part of the book series: The Receptors ((REC,volume 29))

Abstract

This chapter reviews the current preclinical research on the significance of central γ-amino butyric acid (GABA)B receptors in substance use disorder (SUD) and the SUD potential pharmacotherapy based on GABAB receptor ligands. We focused on the role of GABAB receptors in the effects of psychostimulants, opioids, and nicotine in various preclinical behavioral models used in drug addiction research. We provide an overview of the neurochemical mechanisms underlying the interactions between GABAB receptors localized to the mesocorticolimbic dopamine system and drugs of abuse. Finally we discuss the efficacy of GABAB receptor agonists in treatment of human drug addicts. On the whole, the presented data provide compelling preclinical evidence that GABAB receptor agonists and positive allosteric modulators may have efficacy in the treatment of SUD, with GABAB receptor positive allosteric modulators having a better pharmacological profile than orthosteric agonists. There is the need for additional clinical studies to ascertain whether preclinical data translate to the human.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Addolorato, G., Leggio, L., Hopf, F. W., Diana, M., & Bonci, A. (2012). Novel therapeutic strategies for alcohol and drug addiction: Focus on GABA, ion channels and transcranial magnetic stimulation. Neuropsychopharmacology, 37, 163–177.

    Article  CAS  PubMed  Google Scholar 

  • Agabio, R., & Colombo, G. (2015). GABAB receptor as therapeutic target for drug addiction: From baclofen to positive allosteric modulators. Psychiatria Polska, 49, 215–223.

    Article  PubMed  Google Scholar 

  • Agrawal, A., Pergadia, M. L., Saccone, S. F., Hinrichs, A. L., Lessov-Schlaggar, C. N., Saccone, N. L., et al. (2008). Gamma-aminobutyric acid receptor genes and nicotine dependence: Evidence for association from a case-control study. Addiction, 103, 1027–1038.

    Article  PubMed  Google Scholar 

  • Akhondzadeh, S., Ahmadi-Abhari, S. A., Assadi, S. M., Shabestari, O. L., Kashani, A. R., & Farzanehgan, Z. M. (2000). Double-blind randomized controlled trial of baclofen vs. clonidine in the treatment of opiates withdrawal. Journal of Clinical Pharmacy and Therapeutics, 25, 347–353.

    Article  CAS  PubMed  Google Scholar 

  • Arora, D., Hearing, M., Haluk, D. M., Mirkovic, K., Fajardo-Serrano, A., Wessendorf, M. W., et al. (2011). Acute cocaine exposure weakens GABA(B) receptor-dependent G-protein-gated inwardly rectifying K+ signaling in dopamine neurons of the ventral tegmental area. Journal of Neuroscience, 31, 12251–12257.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Assadi, S. M., Radgoodarzi, R., & Ahmadi-Abhari, S. A. (2003). Baclofen for maintenance treatment of opioid dependence: A randomized double-blind placebo-controlled clinical trial. BMC Psychiatry, 3, 16.

    Article  PubMed  PubMed Central  Google Scholar 

  • Aulakh, C. S., Ghosh, B., & Pradhan, S. N. (1979). Actions and interactions of cocaine on self-stimulation behavior in rats. Psychopharmacology, 63, 75–79.

    Article  CAS  PubMed  Google Scholar 

  • Bartoletti, M., Colantoni, A., De Luca, V., & Gaiardi, M. (2010). Single and repeated baclofen treatment attenuates the discriminative stimulus effects of morphine in rats. Pharmacology, Biochemistry and Behavior, 97, 279–283.

    Article  CAS  PubMed  Google Scholar 

  • Bartoletti, M., Gubellini, C., Ricci, F., & Gaiardi, M. (2004). The GABAB agonist baclofen blocks the expression of sensitisation to the locomotor stimulant effect of amphetamine. Behavioral Pharmacology, 15, 397–401.

    Article  CAS  Google Scholar 

  • Bartoletti, M., Gubellini, C., Ricci, F., & Gaiardi, M. (2005). Baclofen blocks the development of sensitization to the locomotor stimulant effect of amphetamine. Behavioral Pharmacology, 16, 553–558.

    Article  CAS  Google Scholar 

  • Bartoletti, M., Ricci, F., & Gaiardi, M. (2007). A GABA(B) agonist reverses the behavioral sensitization to morphine in rats. Psychopharmacology, 192, 79–85.

    Article  CAS  PubMed  Google Scholar 

  • Beuten, J., Ma, J. Z., Payne, T. J., Dupont, R. T., Crews, K. M., Somes, G., et al. (2005). Single- and multilocus allelic variants within the GABA(B) receptor subunit 2 (GABAB2) gene are significantly associated with nicotine dependence. The American Journal of Human Genetics, 76, 859–864.

    Article  CAS  PubMed  Google Scholar 

  • Bexis, S., Ong, J., & White, J. (2001). Attenuation of morphine withdrawal signs by the GABA(B) receptor agonist baclofen. Life Sciences, 70, 395–401.

    Article  CAS  PubMed  Google Scholar 

  • Bocklisch, C., Pascoli, V., Wong, J. C. Y., House DRC, Yvon, C., de Roo, M., et al. (2013). Cocaine disinhibits dopamine neurons by potentiation of GABA transmission in the ventral tegmental area. Science, 341, 1521–1525.

    Article  CAS  PubMed  Google Scholar 

  • Bowery, N. G., Hudson, A. L., & Price, G. W. (1987). GABAA and GABAB receptor site distribution in the rat central nervous system. Neuroscience, 20, 365–383.

    Article  CAS  PubMed  Google Scholar 

  • Boyes, J., & Bolam, J. P. (2003). The subcellular localization of GABA(B) receptor subunits in the rat substantia nigra. European Journal of Neuroscience, 18, 3279–3293.

    Article  PubMed  Google Scholar 

  • Brebner, K., Ahn, S., & Phillips, A. G. (2005). Attenuation of d-amphetamine self-administration by baclofen in the rat: Behavioral and neurochemical correlates. Psychopharmacology, 177, 409–417.

    Article  CAS  PubMed  Google Scholar 

  • Brebner, K., Froestl, W., Andrews, M., Phelan, R., & Roberts, D. C. (1999). The GABA(B) agonist CGP 44532 decreases cocaine self-administration in rats: Demonstration using a progressive ratio and a discrete trials procedure. Neuropharmacology, 38, 1797–1804.

    Article  CAS  PubMed  Google Scholar 

  • Brebner, K., Froestl, W., & Roberts, D. C. (2002). The GABA(B) antagonist CGP56433A attenuates the effect of baclofen on cocaine but not heroin self-administration in the rat. Psychopharmacology, 160, 49–55.

    Article  CAS  PubMed  Google Scholar 

  • Brebner, K., Phelan, R., & Roberts, D. C. (2000a). Effect of baclofen on cocaine self-administration in rats reinforced under fixed-ratio 1 and progressive-ratio schedules. Psychopharmacology, 148, 314–321.

    Article  CAS  PubMed  Google Scholar 

  • Brebner, K., Phelan, R., & Roberts, D. C. (2000b). Intra-VTA baclofen attenuates cocaine self-administration on a progressive ratio schedule of reinforcement. Pharmacology, Biochemistry and Behavior, 66, 857–862.

    Article  CAS  PubMed  Google Scholar 

  • Brown, J. M., Hanson, G. R., & Fleckenstein, A. E. (2001). Cocaine-induced increases in vesicular dopamine uptake: Role of dopamine receptors. Journal of Pharmacol and Experimental Therapeutics, 298, 1150–1153.

    CAS  Google Scholar 

  • Brown, M. T. C., Tan, K. R., O’Connor, E. C., Nikonenko, I., Muller, D., & Lüscher, C. (2012). Ventral tegmental area GABA projections pause accumbal cholinergic interneurons to enhance associative learning. Nature, 492, 452–456.

    Article  CAS  PubMed  Google Scholar 

  • Cachope, R., Mateo, Y., Mathur, B. N., Irving, J., Wang, H. L., Morales, M., et al. (2012). Selective activation of cholinergic interneurons enhances accumbal phasic dopamine release: Setting the tone for reward processing. Cell Reports, 2, 33–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Campbell, U. C., Lac, S. T., & Carroll, M. E. (1999). Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats. Psychopharmacology, 143, 209–214.

    Article  CAS  PubMed  Google Scholar 

  • Cedillo, L. N., & Miranda, F. (2013). Effects of co-administration of the GABAB receptor agonist baclofen and a positive allosteric modulator of the GABAB receptor, CGP7930, on the development and expression of amphetamine-induced locomotor sensitization in rats. Pharmacological Reports, 65, 1132–1143.

    Article  CAS  PubMed  Google Scholar 

  • Chen, Y., Phillips, K., Minton, G., & Sher, E. (2005). GABA(B) receptor modulators potentiate baclofen-induced depression of dopamine neuron activity in the rat ventral tegmental area. British Journal of Pharmacology, 144, 926–932.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Contet, C., Filliol, D., Matifas, A., & Kieffer, B. L. (2008). Morphine-induced analgesic tolerance, locomotor sensitization and physical dependence do not require modification of mu opioid receptor, cdk5 and adenylate cyclase activity. Neuropharmacology, 54, 475–486.

    Article  CAS  PubMed  Google Scholar 

  • Corrigall, W. A., Coen, K. M., Adamson, K. L., Chow, B. L., & Zhang, J. (2000). Response of nicotine self-administration in the rat to manipulations of mu-opioid and gamma-aminobutyric acid receptors in the ventral tegmental area. Psychopharmacology, 149, 107–114.

    Article  CAS  PubMed  Google Scholar 

  • Cousins, M. S., Stamat, H. M., & de Wit, H. (2001). Effects of a single dose of baclofen on self-reported subjective effects and tobacco smoking. Nicotine and Tobacco Research, 3, 123–129. Erratum in: Nicotine Tob Res 3:409.

    Article  CAS  PubMed  Google Scholar 

  • Cragg, S. J., & Rice, M. E. (2004). Dancing past the DAT at a DA synapse. Trends in Neurosciences, 27, 270–277.

    Article  CAS  PubMed  Google Scholar 

  • Creed, M. C., Ntamati, N. R., & Tan, K. R. (2014). VTA GABA neurons modulate specific learning behaviors through the control of dopamine and cholinergic systems. Frontiers in Behavioral Neuroscience, 8, 8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Di Chiara, G., Tanda, G., Bassareo, V., Pontieri, F., Acquas, E., Fenu, S., et al. (1999). Drug addiction as a disorder of associative learning. Role of nucleus accumbens shell/extended amygdala dopamine. The Annals of the New York Academy of Sciences, 877, 461–485.

    Article  PubMed  Google Scholar 

  • Di Ciano, P., & Everitt, B. J. (2003). The GABA(B) receptor agonist baclofen attenuates cocaine- and heroin-seeking behavior by rats. Neuropsychopharmacology, 28, 510–518.

    Article  PubMed  CAS  Google Scholar 

  • Diaz, S. L., Barros, V. G., Antonelli, M. C., Rubio, M. C., & Balerio, G. N. (2006). Morphine withdrawal syndrome and its prevention with baclofen: Autoradiographic study of mu-opioid receptors in prepubertal male and female mice. Synapse, 60, 132–134.

    Article  CAS  PubMed  Google Scholar 

  • Diaz, S. L., Kemmling, A. K., Bonavita, C. D., Rubio, M. C., & Balerio, G. N. (2004). Baclofen reestablishes micro-opioid receptor levels modified by morphine withdrawal syndrome in either sex. Synapse, 54, 24–29.

    Article  CAS  PubMed  Google Scholar 

  • Diaz, S. L., Kemmling, A. K., Rubio, M. C., & Balerio, G. N. (2001). Lack of sex-related differences in the prevention by baclofen of the morphine withdrawal syndrome in mice. Behavioral Pharmacology, 12, 75–79.

    Article  CAS  Google Scholar 

  • Erhardt, S., Mathé, J. M., Chergui, K., Engberg, G., & Svensson, T. H. (2002). GABA(B) receptor-mediated modulation of the firing pattern of ventral tegmental area dopamine neurons in vivo. Naunyn-Schmiedeberg’s Archives of Pharmacology, 365, 173–180.

    Article  CAS  PubMed  Google Scholar 

  • Fadda, P., Scherma, M., Fresu, A., Collu, M., & Fratta, W. (2003). Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat. Synapse, 50, 1–6.

    Article  CAS  PubMed  Google Scholar 

  • Fattore, L., Cossu, G., Martellotta, M. C., & Fratta, W. (2002). Baclofen antagonizes intravenous self-administration of nicotine in mice and rats. Alcohol and Alcoholism, 37, 495–498.

    Article  CAS  PubMed  Google Scholar 

  • Fattore, L., Spano, M. S., Cossu, G., Scherma, M., Fratta, W., & Fadda, P. (2009). Baclofen prevents drug-induced reinstatement of extinguished nicotine-seeking behaviour and nicotine place preference in rodents. European Neuropsychopharmacology, 19, 487–498.

    Article  CAS  PubMed  Google Scholar 

  • Ferraro, L., Beggiato, S., Marcellino, D., Frankowska, M., Filip, M., Agnati, L. F., et al. (2010). Nanomolar concentrations of cocaine enhance D2-like agonist-induced inhibition of the K+-evoked [3H]-dopamine efflux from rat striatal synaptosomes: A novel action of cocaine. Journal of Neural Transmission, 17, 593–597.

    Article  CAS  Google Scholar 

  • Fibiger, H. C., & Phillips, A. G. (1974). Role of dopamine and norepinephrine in the chemistry of reward. Journal of Psychiatric Research, 11, 135–143.

    Article  CAS  PubMed  Google Scholar 

  • Filip, M., Alenina, N., Bader, M., & Przegaliński, E. (2010). Behavioral evidence for the significance of serotoninergic (5-HT) receptors in cocaine addiction. Addiction Biology, 15, 227–249.

    Article  CAS  PubMed  Google Scholar 

  • Filip, M., & Frankowska, M. (2007). Effects of GABA(B) receptor agents on cocaine priming, discrete contextual cue and food induced relapses. European Journal of Pharmacology, 571, 166–173.

    Article  CAS  PubMed  Google Scholar 

  • Filip, M., & Frankowska, M. (2008). GABA(B) receptors in drug addiction. Pharmacological Reports, 60, 755–770.

    CAS  PubMed  Google Scholar 

  • Filip, M., Frankowska, M., & Przegaliński, E. (2007). Effects of GABA(B) receptor antagonist, agonists and allosteric positive modulator on the cocaine-induced self-administration and drug discrimination. European Journal of Pharmacology, 574, 148–157.

    Article  CAS  PubMed  Google Scholar 

  • Filip, M., Frankowska, M., Sadakierska-Chudy, A., Suder, A., Szumiec, L., Mierzejewski, P., et al. (2015). GABAB receptors as a therapeutic strategy in substance use disorders: Focus on positive allosteric modulators. Neuropharmacology, 88, 36–47.

    Article  CAS  PubMed  Google Scholar 

  • Fleckenstein, A. E., Volz, T. J., Riddle, E. L., Gibb, J. W., & Hanson, G. R. (2007). New insights into the mechanism of action of amphetamines. Annual Review of Pharmacology and Toxicology, 47, 681–698.

    Article  CAS  PubMed  Google Scholar 

  • Frankowska, M., Nowak, E., & Filip, M. (2009). Effects of GABAB receptor agonists on cocaine hyperlocomotor and sensitizing effects in rats. Pharmacological Reports, 61, 1042–1049.

    Article  CAS  PubMed  Google Scholar 

  • Frankowska, M., Wydra, K., Faron-Górecka, A., Zaniewska, M., Kuśmider, M., & Dziedzicka-Wasylewska, M. (2008a). Neuroadaptive changes in the rat brain GABA(B) receptors after withdrawal from cocaine self-administration. European Journal of Pharmacology, 599, 58–64.

    Article  CAS  PubMed  Google Scholar 

  • Frankowska, M., Wydra, K., Faron-Górecka, A., Zaniewska, M., Kuśmider, M., & Dziedzicka-Wasylewska, M. (2008b). Alterations in gamma-aminobutyric acid(B) receptor binding in the rat brain after reinstatement of cocaine-seeking behavior. Pharmacological Reports, 60, 834–843.

    CAS  PubMed  Google Scholar 

  • Fricks-Gleason, A. N., & Marshall, J. F. (2008). Post-retrieval beta-adrenergic receptor blockade: Effects on extinction and reconsolidation of cocaine-cue memories. Learning and Memory, 15, 643–648.

    Article  PubMed  PubMed Central  Google Scholar 

  • Froger-Colléaux, C., & Castagné, V. (2016). Effects of baclofen and raclopride on reinstatement of cocaine self-administration in the rat. European Journal of Pharmacology, 777, 147–155.

    Article  PubMed  CAS  Google Scholar 

  • Fu, Z., Yang, H., Xiao, Y., Zhao, G., & Huang, H. (2012). The γ-aminobutyric acid type B (GABAB) receptor agonist baclofen inhibits morphine sensitization by decreasing the dopamine level in rat nucleus accumbens. Behavioral and Brain Functions, 8, 20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gassmann, M., & Bettler, B. (2012). Regulation of neuronal GABAB receptor functions by subunit composition. Nature Reviews Neuroscience, 13, 380–394.

    Article  CAS  PubMed  Google Scholar 

  • Gatley, S. J., & Volkow, N. D. (1998). Addiction and imaging of the living human brain. Drug and Alcohol Dependence, 511, 97–108.

    Article  Google Scholar 

  • Green, A. R., Mechan, A. O., Elliott, J. M., O’Shea, E., & Colado, M. I. (2003). The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”). Pharmacological Reviews, 55, 463–508.

    Article  CAS  PubMed  Google Scholar 

  • Halbout, B., Quarta, D., Valerio, E., Heidbreder, C. A., & Hutcheson, D. M. (2011). The GABA-B positive modulator GS39783 decreases psychostimulant conditioned-reinforcement and conditioned-reward. Addiction Biology, 16, 416–427.

    Article  CAS  PubMed  Google Scholar 

  • Heinrichs, S. C., Leite-Morris, K. A., Carey, R. J., & Kaplan, G. B. (2010). Baclofen enhances extinction of opiate conditioned place preference. Behavioural Brain Research, 207, 353–359.

    Article  CAS  PubMed  Google Scholar 

  • Hong, S., Jhou, T. C., Smith, M., Saleem, K. S., & Hikosaka, O. (2011). Negative reward signals from the lateral habenula to dopamine neurons are mediated by rostromedial tegmental nucleus in primates. Journal of Neuroscience, 31, 11457–11471.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ishikawa, M., Otaka, M., Neumann, P. A., Wang, Z., Cook, J. M., Schlüter, O. M., et al. (2013). Exposure to cocaine regulates inhibitory synaptic transmission from the ventral tegmental area to the nucleus accumbens. Journal of Physiology, 591, 4827–4841.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jennings, J. H., Sparta, D. R., Stamatakis, A. M., Ung, R. L., Pleil, K. E., & Kash, T. L. (2013). Distinct extended amygdala circuits for divergent motivational states. Nature, 496, 224–228.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kahlig, K. M., Binda, F., Khoshbouei, H., Blakely, R. D., McMahon, D. G., & Javitch, J. A. (2005). Amphetamine induces dopamine efflux through a dopamine transporter channel. Proceedings of the National Academy of Sciences of the United States of America, 102, 3495–3500.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kahn, R., Biswas, K., Childress, A. R., Shoptaw, S., Fudala, P. J., Gorgon, L., et al. (2009). Multi-center trial of baclofen for abstinence initiation in severe cocaine-dependent individuals. Drug and Alcohol Dependence, 103, 59–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kalivas, P. W. (2009). The glutamate homeostasis hypothesis of addiction. Nature Review Neuroscience, 10, 561–572.

    Article  CAS  Google Scholar 

  • Kaplan, G. B., Leite-Morris, K. A., Joshi, M., Shoeb, M. H., & Carey, R. J. (2003). Baclofen inhibits opiate-induced conditioned place preference and associated induction of Fos in cortical and limbic regions. Brain Research, 987, 122–125.

    Article  CAS  PubMed  Google Scholar 

  • Kemmling, A. K., Rubio, M. C., & Balerio, G. N. (2002). Baclofen prevents morphine withdrawal irrespective of seasonal variation. Behavioral Pharmacology, 13, 87–92.

    Article  CAS  Google Scholar 

  • Kenny, P. J., & Markou, A. (2006). Nicotine self-administration acutely activates brain reward systems and induces a long-lasting increase in reward sensitivity. Neuropsychopharmacology, 31, 1203–1211.

    CAS  PubMed  Google Scholar 

  • Lacey, C. J., Boyes, J., Gerlach, O., Chen, L., Magill, P. J., & Bolam, J. P. (2005). GABA(B) receptors at glutamatergic synapses in the rat striatum. Neuroscience, 136, 1083–1095.

    Article  CAS  PubMed  Google Scholar 

  • Laviolette, S. R., & van der Kooy, D. (2003). Blockade of mesolimbic dopamine transmission dramatically increases sensitivity to the rewarding effects of nicotine in the ventral tegmental area. Molecular Psychiatry, 8, 50–59.

    Article  CAS  PubMed  Google Scholar 

  • Le Foll, B., Wertheim, C. E., & Goldberg, S. R. (2008). Effects of baclofen on conditioned rewarding and discriminative stimulus effects of nicotine in rats. Neuroscience Letters, 443, 236–240.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Lecca, S., Melis, M., Luchicchi, A., Ennas, M. G., Castelli, M. P., & Muntoni, A. L. (2011). Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells. Neuropsychopharmacology, 36, 589–602.

    Article  CAS  PubMed  Google Scholar 

  • Leite-Morris, K. A., Fukudome, E. Y., Shoeb, M. H., & Kaplan, G. B. (2004). GABA(B) receptor activation in the ventral tegmental area inhibits the acquisition and expression of opiate-induced motor sensitization. Journal of Pharmacol and Experimental Therapeutics, 308, 667–678.

    Article  CAS  Google Scholar 

  • Lhuillier, L., Mombereau, C., Cryan, J. F., & Kaupmann, K. (2007). GABA(B) receptor-positive modulation decreases selective molecular and behavioral effects of cocaine. Neuropsychopharmacology, 32, 388–398.

    Article  CAS  PubMed  Google Scholar 

  • Li, S. M., Yin, L. L., Ren, Y. H., Pan, L. S., & Zheng, J. W. (2001). GABA(B) receptor agonist baclofen attenuates the development and expression of d-methamphetamine-induced place preference in rats. Life Sciences, 70, 349–356.

    Article  CAS  PubMed  Google Scholar 

  • Liang, F., Hatanaka, Y., Saito, H., Yamamori, T., & Hashikawa, T. (2000). Differential expression of gamma-aminobutyric acid type B receptor-1a and-1b mRNA variants in GABA and non-GABAergic neurons of the rat brain. Journal of Comparative Neurology, 416, 475–495.

    Article  CAS  PubMed  Google Scholar 

  • Ling, W., Shoptaw, S., & Majewska, D. (1998). Baclofen as a cocaine anti-craving medication: A preliminary clinical study. Neuropsychopharmacology, 18, 403–404.

    Article  CAS  PubMed  Google Scholar 

  • Lobina, C., Carai, M. A. M., Froestl, W., Mugnaini, C., Pasquini, S., Corelli, F., et al. (2011). Activation of the GABA(B) receptor prevents nicotine-induced locomotor stimulation in mice. Frontiers in Psychiatry, 2, 76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lüscher, C., & Malenka, R. C. (2011). Drug-evoked synaptic plasticity in addiction: From molecular changes to circuit remodeling. Neuron, 69, 650–663.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Lüscher, C., & Ungless, M. A. (2006). The mechanistic classification of addictive drugs. PLoS Medicine, 3, e437.

    Article  PubMed  PubMed Central  Google Scholar 

  • Mansvelder, H. D., Keath, J. R., & McGehee, D. S. (2002). Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron, 33, 905–919.

    Article  CAS  PubMed  Google Scholar 

  • Margolis, E. B., Lock, H., Hjelmstad, G. O., & Fields, H. L. (2006). The ventral tegmental area revisited: Is there an electrophysiological marker for dopaminergic neurons? Journal of Physiology, 577, 907–924.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Markou, A., & Koob, G. F. (1991). Postcocaine anhedonia. An animal model of cocaine withdrawal. Neuropsychopharmacology, 4, 17–26.

    CAS  PubMed  Google Scholar 

  • Meng, S., Quan, W., Qi, X., Su, Z., & Yang, S. (2014). Effect of baclofen on morphine-induced conditioned place preference, extinction, and stress-induced reinstatement in chronically stressed mice. Psychopharmacology, 231, 27–36.

    Article  CAS  PubMed  Google Scholar 

  • Miranda, F., Jiménez, J. C., Cedillo, L. N., Sandoval-Sánchez, A., Millán-Mejía, P., & Sánchez-Castillo, H. (2009). The GABA-B antagonist 2-hydroxysaclofen reverses the effects of baclofen on the discriminative stimulus effects of D-amphetamine in the conditioned taste aversion procedure. Pharmacology, Biochemistry and Behavior, 93, 25–30.

    Article  CAS  PubMed  Google Scholar 

  • Mombereau, C., Lhuillier, L., Kaupmann, K., & Cryan, J. F. (2007). GABAB receptor-positive modulation-induced blockade of the rewarding properties of nicotine is associated with a reduction in nucleus accumbens DeltaFosB accumulation. Journal of Pharmacol and Experimental Therapeutics, 321, 172–177.

    Article  CAS  Google Scholar 

  • Moss, J., & Bolam, J. P. (2008). A dopaminergic axon lattice in the striatum and its relationship with cortical and thalamic terminals. Journal of Neuroscience, 28, 11221–11230.

    Article  CAS  PubMed  Google Scholar 

  • Munzar, P., Kutkat, S. W., Miller, C. R., & Goldberg, S. R. (2007). Failure of baclofen to modulate discriminative-stimulus effects of cocaine or methamphetamine in rats. European Journal of Pharmacology, 408, 169–174.

    Article  Google Scholar 

  • Niu, H., Shang, B., Sun, N., Li, L., Guan, Y., Yu, H., et al. (2008). Baclofen inhibited the morphine-induced conditioned place preference and withdrawal syndromes. Zoological Research, 29, 621–626.

    Article  CAS  Google Scholar 

  • Omelchenko, N., & Sesack, S. R. (2006). Cholinergic axons in the rat ventral tegmental area synapse preferentially onto mesoaccumbens dopamine neurons. Journal of Comparative Neurology, 494, 863–875.

    Article  PubMed  PubMed Central  Google Scholar 

  • Paterson, N. E., Froestl, W., & Markou, A. (2004). The GABAB receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat. Psychopharmacology, 172, 179–186.

    Article  CAS  PubMed  Google Scholar 

  • Paterson, N. E., Froestl, W., & Markou, A. (2005). Repeated administration of the GABAB receptor agonist CGP44532 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine-seeking in rats. Neuropsychopharmacology, 30, 119–128.

    Article  CAS  PubMed  Google Scholar 

  • Paterson, N. E., Vlachou, S., Guery, S., Kaupmann, K., Froestl, W., & Markou, A. (2008). Positive modulation of GABA(B) receptors decreased nicotine self-administration and counteracted nicotine-induced enhancement of brain reward function in rats. Journal of Pharmacol and Experimental Therapeutics, 326, 306–314.

    Article  CAS  Google Scholar 

  • Pin, J. P., & Prézeau, L. (2007). Allosteric modulators of GABAB receptors: Mechanism of action and therapeutic perspective. Current Neuropharmacology, 5, 195–201.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ramshini, E., Alaei, H., Reisi, P., Alaei, S., & Shahidani, S. (2013). The role of GABAB receptors in morphine self-administration. International Journal of Preventive Medicine, 4, 158–164.

    PubMed  PubMed Central  Google Scholar 

  • Ranaldi, R., & Poeggel, K. (2002). Baclofen decreases methamphetamine self-administration in rats. Neuroreport, 13, 1107–1110.

    Article  CAS  PubMed  Google Scholar 

  • Riahi, E., Mirzaii-Dizgah, I., Karimian, S. M., Sadeghipour, H. R., & Dehpour, A. R. (2009). Attenuation of morphine withdrawal signs by a GABAB receptor agonist in the locus coeruleus of rats. Behavioural Brain Research, 196, 11–14.

    Article  CAS  PubMed  Google Scholar 

  • Riddle, E. L., Kokoshka, J. M., Wilkins, D. G., Hanson, G. R., & Fleckenstein, A. E. (2002). Tolerance to the neurotoxic effects of methamphetamine in young rats. European Journal of Pharmacology, 435, 181–185.

    Article  CAS  PubMed  Google Scholar 

  • Roberts, D. C., Andrews, M. M., & Vickers, G. J. (1996). Baclofen attenuates the reinforcing effects of cocaine in rats. Neuropsychopharmacology, 15, 417–423.

    Article  CAS  PubMed  Google Scholar 

  • Robinson, T. E., & Berridge, K. C. (2001). Incentive-sensitization and addiction. Addiction, 96, 103–114.

    Article  CAS  PubMed  Google Scholar 

  • Rothman, R. B., & Baumann, M. H. (2003). Monoamine transporters and psychostimulant drugs. European Journal of Pharmacology, 479, 23–40.

    Article  CAS  PubMed  Google Scholar 

  • Sagara, H., Kitamura, Y., Yae, T., Shibata, K., Suemaru, K., Sendo, T., et al. (2008). Nicotinic acetylcholine alpha4beta2 receptor regulates the motivational effect of intracranial self-stimulation behavior in the runway method. Journal of Pharmacological Sciences, 108, 455–461.

    Article  CAS  PubMed  Google Scholar 

  • Sahraei, H., Amiri, Y. A., Haeri-Rohani, A., Sepehri, H., Salimi, S. H., Pourmotabbed, A., et al. (2005). Different effects of GABAergic receptors located in the ventral tegmental area on the expression of morphine-induced conditioned place preference in rat. European Journal of Pharmacology, 524, 95–101.

    Article  CAS  PubMed  Google Scholar 

  • Sahraei, H., Etemadi, L., Rostami, P., Pourmotabbed, A., Zarrindast, M. R., Shams, J., et al. (2009). GABAB receptors within the ventral tegmental area are involved in the expression and acquisition of morphine-induced place preference in morphine-sensitized rats. Pharmacology, Biochemistry and Behavior, 91, 409–416.

    Article  CAS  PubMed  Google Scholar 

  • Shoaib, M., Swanner, L. S., Beyer, C. E., Goldberg, S. R., & Schindler, C. W. (1998). The GABAB agonist baclofen modifies cocaine self-administration in rats. Behavioral Pharmacology, 9, 195–206.

    CAS  Google Scholar 

  • Shoptaw, S., Yang, X., Rotheram-Fuller, E. J., Hsieh, Y. C., Kintaudi, P. C., Charuvastra, V. C., et al. (2003). Randomized placebo-controlled trial of baclofen for cocaine dependence: Preliminary effects for individuals with chronic patterns of cocaine use. Journal of Clinical Psychiatry, 64, 1440–1448.

    Article  CAS  PubMed  Google Scholar 

  • Sitte, H. H., Huck, S., Reither, H., Boehm, S., Singer, E. A., & Pifl, C. (1998). Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter. Journal of Neurochemistry, 71, 1289–1297.

    Article  CAS  PubMed  Google Scholar 

  • Slattery, D. A., Markou, A., Froestl, W., & Cryan, J. F. (2005). The GABAB receptor-positive modulator GS39783 and the GABAB receptor agonist baclofen attenuate the reward-facilitating effects of cocaine: Intracranial self-stimulation studies in the rat. Neuropsychopharmacology, 30, 2065–2072.

    Article  CAS  PubMed  Google Scholar 

  • Smith, M. A., Greene-Naples, J. L., Lyle, M. A., Iordanou, J. C., & Felder, J. N. (2009). The effects of repeated opioid administration on locomotor activity: I. Opposing actions of mu and kappa receptors. Journal of Pharmacology of Experimental and Therapeutics, 330, 468–475.

    Article  CAS  Google Scholar 

  • Smith, M. A., Yancey, D. L., Morgan, D., Liu, Y., Froestl, W., & Roberts, D. C. (2004). Effects of positive allosteric modulators of the GABAB receptor on cocaine self-administration in rats. Psychopharmacology, 173, 105–111.

    Article  CAS  PubMed  Google Scholar 

  • Solecki, W., Krówka, T., Filip, M., & Przewłocki, R. (2005). Role of opioidergic mechanisms and GABA uptake inhibition in the heroin-induced discriminative stimulus effects in rats. Pharmacological Reports, 57, 744–754.

    CAS  PubMed  Google Scholar 

  • Spano, M. S., Fattore, L., Fratta, W., & Fadda, P. (2007). The GABAB receptor agonist baclofen prevents heroin-induced reinstatement of heroin-seeking behavior in rats. Neuropharmacology, 52, 1555–1562.

    Article  CAS  PubMed  Google Scholar 

  • Steketee, J. D., & Kalivas, P. W. (2011). Drug wanting: Behavioral sensitization and relapse to drug-seeking behavior. Pharmacological Reviews, 63, 348–365.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sulzer, D. (2011). How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron, 69, 628–649.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sulzer, D., Chen, T. K., Lau, Y. Y., Kristensen, H., Rayport, S., & Ewing, A. (1995). Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. Journal of Neuroscience, 15, 4102–4108.

    CAS  PubMed  Google Scholar 

  • Suzuki, T., Nurrochmad, A., Ozaki, M., Khotib, J., Nakamura, A., Imai, S., et al. (2005). Effect of a selective GABA(B) receptor agonist baclofen on the mu-opioid receptor agonist-induced antinociceptive, emetic and rewarding effects. Neuropharmacology, 49, 1121–1131.

    Article  CAS  PubMed  Google Scholar 

  • Tolu, S., Eddine, R., Marti, F., David, V., Graupner, M., Pons, S., et al. (2013). Co-activation of VTA DA and GABA neurons mediates nicotine reinforcement. Molecular Psychiatry, 18, 382–393.

    Article  CAS  PubMed  Google Scholar 

  • Tsuji, M., Nakagawa, Y., Ishibashi, Y., Yoshii, T., Takashima, T., Shimada, M., et al. (1996). Activation of ventral tegmental GABAB receptors inhibits morphine-induced place preference in rats. European Journal of Pharmacology, 313, 169–173.

    Article  CAS  PubMed  Google Scholar 

  • Tyacke, R. J., Lingford-Hughes, A., Reed, L. J., & Nutt, D. J. (2010). GABAB receptors in addiction and its treatment. Advances in Pharmacology, 58, 373–396.

    Article  CAS  PubMed  Google Scholar 

  • Varani, A. P., Antonelli, M. C., & Balerio, G. N. (2013) Mecamylamine-precipitated nicotine withdrawal syndrome and its prevention with baclofen: An autoradiographic study of α4β2 nicotinic acetylcholine receptors in mice. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 44, 217–225.

    Google Scholar 

  • Varani, A. P., Aso, E., Moutinho, L. M., Maldonado, R., & Balerio, G. N. (2014). Attenuation by baclofen of nicotine rewarding properties and nicotine withdrawal manifestations. Psychopharmacology, 231, 3031–3040.

    Article  CAS  PubMed  Google Scholar 

  • Varani, A. P., Pedrón, V. T., Machado, L. M., Antonelli, M. C., Bettler, B., & Balerio, G. N. (2015). Lack of GABAB receptors modifies behavioural and biochemical alterations induced by precipitated nicotine withdrawal. Neuropharmacology, 90, 90–101.

    Article  CAS  PubMed  Google Scholar 

  • Vlachou, S., Guery, S., Froestl, W., Banerjee, D., Benedict, J., Finn, M. G., et al. (2011). Repeated administration of the GABAB receptor positive modulator BHF177 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine seeking in rats. Psychopharmacology, 215, 117–128.

    Article  CAS  PubMed  Google Scholar 

  • Vlachou, S., & Markou, A. (2010). GABAB receptors in reward processes. Advances in Pharmacology, 58, 315–371.

    Article  CAS  PubMed  Google Scholar 

  • Voigt, R. M., Herrold, A. A., & Napier, T. C. (2011a). Baclofen facilitates the extinction of methamphetamine-induced conditioned place preference in rats. Behavioral Neuroscience, 125, 261–267.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Voigt, R. M., Herrold, A. A., Riddle, J. L., & Napier, T. C. (2011b). Administration of GABA(B) receptor positive allosteric modulators inhibit the expression of previously established methamphetamine-induced conditioned place preference. Behavioural Brain Research, 216, 419–423.

    Article  CAS  PubMed  Google Scholar 

  • Vos, T., Barber, R. M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., et al. (2015). Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet, 386, 743–800.

    Article  Google Scholar 

  • Willick, M. L., & Kokkinidis, L. (1995). The effects of ventral tegmental administration of GABAA, GABAB and NMDA receptor agonists on medial forebrain bundle self-stimulation. Behavioural Brain Research, 70, 31–36.

    Article  CAS  PubMed  Google Scholar 

  • Wirtshafter, D., & Sheppard, A. C. (2001). Localization of GABA(B) receptors in midbrain monoamine containing neurons in the rat. Brain Research Bulletin, 56, 1–5.

    Article  CAS  PubMed  Google Scholar 

  • Wise, R. A. (1978). Catecholamine theories of reward: A critical review. Brain Research, 152, 215–247.

    Article  CAS  PubMed  Google Scholar 

  • Wise, R. A. (1987). The role of reward pathways in the development of drug dependence. Pharmacology and Therapeutics, 35, 227–263.

    Article  CAS  PubMed  Google Scholar 

  • Woo, S. H., Kim, H. S., Yun, J. S., Lee, M. K., Oh, K. W., Seong, Y. H., et al. (2001). Inhibition of baclofen on morphine-induced hyperactivity, reverse tolerance and postsynaptic dopamine receptor supersensitivity. Pharmacological Research, 43, 335–340.

    Article  CAS  PubMed  Google Scholar 

  • Xi, Z. X., Spiller, K., & Gardner, E. L. (2009). Mechanism-based medication development for the treatment of nicotine dependence. Acta Pharmacologica Sinica, 30, 723–739.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Xi, Z. X., & Stein, E. A. (1999). Baclofen inhibits heroin self-administration behavior and mesolimbic dopamine release. Journal of Pharmacol and Experimental Therapeutics, 290, 1369–1374.

    CAS  Google Scholar 

  • Xi, Z. X., & Stein, E. A. (2000). Increased mesolimbic GABA concentration blocks heroin self-administration in the rat. Journal of Pharmacol and Experimental Therapeutics, 294, 613–619.

    CAS  Google Scholar 

  • Xi, Z. X., & Stein, E. A. (2002). GABAergic mechanisms of opiate reinforcement. Alcohol and Alcoholism, 37, 485–494.

    Article  CAS  PubMed  Google Scholar 

  • Xia, Y., Driscoll, J. R., Wilbrecht, L., Margolis, E. B., Fields, H. L., & Hjelmstad, G. O. (2011). Nucleus accumbens medium spiny neurons target non-dopaminergic neurons in the ventral tegmental area. Journal of Neuroscience, 31, 7811–7816.

    Article  CAS  PubMed  Google Scholar 

  • Yang, K., Hu, J., Lucero, L., Liu, Q., Zheng, C., Zhen, X., et al. (2009). Distinctive nicotinic acetylcholine receptor functional phenotypes of rat ventral tegmental area dopaminergic neurons. Journal of Physiology, 587, 345–361.

    Article  CAS  PubMed  Google Scholar 

  • Yoon, S. S., Lee, B. H., Kim, H. S., Choi, K. H., Yun, J., Jang, E. Y., et al. (2007). Potential roles of GABA receptors in morphine self-administration in rats. Neuroscience Letters, 428, 33–37.

    Article  CAS  PubMed  Google Scholar 

  • Zaniewska, M., Przegaliński, E., & Filip, M. (2009). Nicotine dependence—human and animal studies, current pharmacotherapies and future perspectives. Pharmacological Reports, 61, 957–965.

    Article  CAS  PubMed  Google Scholar 

  • Zarrindast, M. R., Ghadimi, M., Ramezani-Tehrani, B., & Sahebgharani, M. (2006). Effect of GABA receptor agonists or antagonists on morphine-induced Straub tail in mice. International Journal of Neuroscience, 116, 963–973.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This chapter was supported by the statutory funds of the Institute of Pharmacology (Krakow, Poland).

Conflict of Interest None.

Author information

Authors and Affiliations

  1. Laboratory of Drug Addiction Pharmacology, Institute of Pharmacology Polish Academy of Sciences, Kraków, 31-343, Poland

    Małgorzata Frankowska, Edmund Przegaliński & Małgorzata Filip

Authors
  1. Małgorzata Frankowska
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Edmund Przegaliński
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Małgorzata Filip
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Małgorzata Filip .

Editor information

Editors and Affiliations

  1. Neuroscience Institute, National Research Council of Italy Neuroscience Institute, Cagliari, Italy

    Giancarlo Colombo

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Frankowska, M., Przegaliński, E., Filip, M. (2016). Targeting the GABAB Receptor for the Treatment of Substance Use Disorder. In: Colombo, G. (eds) GABAB Receptor. The Receptors, vol 29. Humana Press, Cham. https://doi.org/10.1007/978-3-319-46044-4_14

Download citation

Publish with us

Policies and ethics

Search

Navigation